Medunik Canada offers treatment options for rare diseases in the therapeutic area of Urea Cycle Disorders (UCDs) and Adrenal Cortical Carinoma (ACC).
For Canadians suffering from rare diseases, orphan drugs available elsewhere in the world could have potentially life-changing or even life-saving effects. By creating strategic alliances with international partners, Medunik Canada brings the following orphan drugs to the Canadian market.
Patient Support Program
At Medunik, we always put patients first. That’s why we believe that no patient should go without access to the medications he or she needs. This is even more important for those suffering from rare diseases, since orphan drugs can mean the difference between life and death. That’s why Medunik Canada is proud to offer complete patient support programs whenever possible.